Cytosorbents (CTSO) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts CTSO Hot Sheet
Join SI Premium – FREE
Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.11), $0.07 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $12 million versus the consensus estimate of $12.27 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Summit Therapeutics (SMMT) Reports In-Line Q2 EPS
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
